• 1
    Chutivongse S, Wilde H, Supich C, et al. Postexposure prophylaxis for rabies with antiserum and intradermal vaccination. Lancet 1990; 335:896898.
  • 2
    World Health Organization. Report of a consultation on intradermal application of human rabies vaccines. WHO: Geneva 1995; WHO/RAB. Res. 95.47.
  • 3
    Wilde H. Rabies, 1996. Intern J Infect Dis 1997; 1:135142.
  • 4
    Bernard KW, Fishbein DB, Miller KD, et al. Preexposure rabies immunization with human diploid cell vaccine: decreased antibody responses in persons immunized in developing countries. Am J Trop Med Hyg 1985; 34 (3) 633645.
  • 5
    Biggs DJ, Schwenke RJ. Longevity of rabies antibody titre in recipients of human diploid cell rabies vaccine. Vaccine 1992; 10:125128.
  • 6
    Kositprapa C, Lirnsuwan K, Wilde H, et al. Immune response to simulated postexposure booster vaccination in volunteers who received preexposure vaccination. Clin Infect Dis 1997; 25:614616.
  • 7
    Smith JS, Yager PA, Baer GM. A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ 1973; 48:535541.
  • 8
    World Health Organization. Expert Committee on Rabies, 8th Report. WHO: Geneva , 1992; 824.
  • 9
    Hemachudha T. Rabies In: VinkenPJ, BruynGW, KlawansHL, eds. Handbook of clinical neurology. Amsterdam : Elsevier 1989:383404.
  • 10
    Wilde H, Sirikawin S, Sabcharoen A, et al. Failures of postexposure treatment of rabies in children. Clin Infect Dis 1996; 22:228232.